Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)

SHE:002873 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	873.38	857.55	953.26	1,087	968.7	750.18
Other Revenue	-	-	0.73	0.88	1.15	0.76
Revenue	873.38	857.55	953.98	1,088	969.84	750.95
Revenue Growth (YoY)	-5.33%	-10.11%	-12.29%	12.15%	29.15%	-2.90%
Cost of Revenue	243.49	227.66	219.39	247.65	201.16	165.86
Gross Profit	629.89	629.89	734.59	840.02	768.69	585.09
Selling, General & Admin	522.67	513.64	589.02	673.99	606.18	474.39
Research & Development	44.39	40.47	38.13	21.58	20.38	13.3
Other Operating Expenses	8.92	8.75	12.99	13.17	13.81	11.52
Operating Expenses	575.98	562.86	639.88	709.27	642.1	498.7
Operating Income	53.91	67.02	94.72	130.75	126.58	86.39
Interest Expense	-	-	-11.8	-10.67	-16.6	-5.47
Interest & Investment Income	-	-	0.92	0.73	1.37	1.42
Currency Exchange Gain (Loss)	-	-	0	-	-	-
Other Non Operating Income (Expenses)	-22.68	-22	1.92	-5.41	-2.93	-2.23
EBT Excluding Unusual Items	31.22	45.02	85.76	115.39	108.42	80.11
Gain (Loss) on Sale of Investments	-0	0.02	-0.72	-0.4	-	-
Gain (Loss) on Sale of Assets	18.94	18.9	-	-0.02	-0.1	-
Asset Writedown	-3.24	-3.19	-0.07	-0.12	-0.37	-0.48
Other Unusual Items	-	-	7.46	6.48	8.69	4.31
Pretax Income	46.91	60.76	92.42	121.34	116.65	83.94
Income Tax Expense	5.97	8.43	11.55	9.83	16.04	9.84
Earnings From Continuing Operations	40.94	52.32	80.87	111.52	100.61	74.1
Net Income	40.94	52.32	80.87	111.52	100.61	74.1
Net Income to Common	40.94	52.32	80.87	111.52	100.61	74.1
Net Income Growth	-42.62%	-35.30%	-27.48%	10.85%	35.76%	3.75%
Shares Outstanding (Basic)	223	220	232	232	227	225
Shares Outstanding (Diluted)	223	220	245	244	245	241
Shares Change (YoY)	-9.10%	-9.91%	0.41%	-0.41%	1.34%	6.59%
EPS (Basic)	0.18	0.24	0.35	0.48	0.44	0.33
EPS (Diluted)	0.18	0.24	0.33	0.46	0.41	0.31
EPS Growth	-36.88%	-28.18%	-27.78%	11.30%	33.96%	-2.66%
Free Cash Flow	24.17	26.68	-23.92	-53.38	18.61	107.62
Free Cash Flow Per Share	0.11	0.12	-0.10	-0.22	0.08	0.45
Dividend Per Share	-	-	0.070	0.100	0.086	0.061
Dividend Growth	-	-	-30.00%	16.69%	40.03%	20.00%
Gross Margin	72.12%	73.45%	77.00%	77.23%	79.26%	77.91%
Operating Margin	6.17%	7.82%	9.93%	12.02%	13.05%	11.50%
Profit Margin	4.69%	6.10%	8.48%	10.25%	10.37%	9.87%
Free Cash Flow Margin	2.77%	3.11%	-2.51%	-4.91%	1.92%	14.33%
EBITDA	89.44	99.31	114.02	155.38	148.33	105.47
EBITDA Margin	10.24%	11.58%	11.95%	14.29%	15.29%	14.04%
D&A For EBITDA	35.54	32.29	19.3	24.64	21.74	19.09
EBIT	53.91	67.02	94.72	130.75	126.58	86.39
EBIT Margin	6.17%	7.82%	9.93%	12.02%	13.05%	11.50%
Effective Tax Rate	12.73%	13.88%	12.49%	8.10%	13.75%	11.72%
Revenue as Reported	-	-	953.98	1,088	969.84	750.95
Advertising Expenses	-	-	43.46	43.15	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.